PON1 activities and oxidative markers of LDL in patients with angiographic ally proven coronary artery disease

被引:39
|
作者
Azarsiz, E
Kayikcioglu, M
Payzin, S
Sözmen, EY
机构
[1] Ege Univ, Fac Med, Dept Biochem, Izmir, Turkey
[2] Ege Univ, Fac Med, Dept Cardiol, Izmir, Turkey
关键词
coronary disease; antioxidant enzymes; PON1; coronary angiography; ox-LDL;
D O I
10.1016/S0167-5273(02)00595-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: There is growing evidence that ox-LDL plays an important role during the atherosclerosis process and PON1 can significantly inhibit generation of lipid peroxidation during LDL oxidation and thus play a role in the in vivo protection by HDL against atherosclerosis. Methods: Twenty-four healthy volunteers and one-hundred and one patients were taken into study, sixty-eight patients had coronary artery disease which was confirmed by coronary angiography. Serum PON1, erythrocyte superoxide dismutase and catalase activities, oxidative markers of LDL were determined along with the routine biochemical parameters in all groups. Results: The indicators of oxidative stress were higher in the patients compared with the controls. No statistically significant difference in any of parameters were observed between the patients who had obstruction with different degrees except for erythrocyte TBARS [24.5 nmol/g Hb in patients with one vessel disease (VD) (n=22), 29.6 nmol/g Hb in patients with two VD (n=26) and 33.5 nmol/g Hb in patients with three VD (n=20)]. Basal and stimulated diene levels were higher in patients who had more diseased vessels than those who had less. Conclusion: The increase in erythrocyte TBARS and CRP levels with the severity of disease supports the reports that showed the inflammatory and oxidative nature of atherosclerosis. In the light of the fact that the well-known classical risk factors for atherosclerosis are closely associated with increased oxidative stress, we propose that the elevation in TBARS levels might be a more marked indicator for the degree of atherosclerosis than the insufficiency in antioxidant enzymes such as SOD and PON1. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:43 / 51
页数:9
相关论文
共 50 条
  • [21] The study of relationship between PON1 activity as well as oxLDL level and coronary artery lesions in patients with coronary artery disease and diabetes mellitus
    Tian, HM
    Lu, CZ
    DIABETOLOGIA, 2005, 48 : A395 - A396
  • [22] Association of PON1 gene promoter DNA methylation with the risk of Clopidogrel resistance in patients with coronary artery disease
    Su, Jia
    Li, Jiyi
    Yu, Qinglin
    Xu, Xiaofeng
    Wang, Jingqiao
    Yang, Jin
    Li, Xiaojing
    Chen, Xiaomin
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2019, 33 (05)
  • [23] PON1 activity in patients with cardiovascular disease
    Murillo-Gonzalez, F. E.
    Ponce-Ruiz, N.
    Xotlanihua-Gervacio, M. C.
    Ponce-Gallegos, J.
    Rojas-Garcia, A. E.
    Bernal-Hernandez, Y. Y.
    Barron-Vivanco, B. S.
    Medina-Diaz, I. M.
    TOXICOLOGY LETTERS, 2016, 259 : S121 - S121
  • [24] LDL Density and Oxidation are Modulated by PON1 Promoter Genotype in Patients with Alzheimer's Disease
    Cagnin, Annachiara
    Leon, Alberta
    Vianello, Daniela
    Colavito, Davide
    Favaretto, Silvia
    Zarantonello, Giulia
    Stecca, Anna
    Ermani, Mario
    Zambon, Alberto
    JOURNAL OF ALZHEIMERS DISEASE, 2013, 34 (02) : 377 - 385
  • [25] Paraoxonase-1 (PON1) promoter region polymorphisms, serum PON1 status and coronary heart disease
    Mackness, Bharti
    Turkie, Wajdi
    Mackness, Mike
    ARCHIVES OF MEDICAL SCIENCE, 2013, 9 (01) : 8 - 13
  • [26] Interaction between metabolic syndrome and PON1 polymorphisms as a determinant of the risk of coronary artery disease
    Martinelli, N
    Girelli, D
    Olivieri, O
    Cavallari, U
    Biscuola, M
    Trabetti, E
    Friso, S
    Pizzolo, F
    Tenuti, I
    Bozzini, C
    Villa, G
    Ceradini, B
    Sandri, M
    Cheng, S
    Grow, MA
    Pignatti, PF
    Corrocher, R
    CLINICAL AND EXPERIMENTAL MEDICINE, 2005, 5 (01) : 20 - 30
  • [27] Interaction between metabolic syndrome and PON1 polymorphisms as a determinant of the risk of coronary artery disease
    N. Martinelli
    D. Girelli
    O. Olivieri
    U. Cavallari
    M. Biscuola
    E. Trabetti
    S. Friso
    F. Pizzolo
    I. Tenuti
    C. Bozzini
    G. Villa
    B. Ceradini
    M. Sandri
    S. Cheng
    M. A. Grow
    P. F. Pignatti
    R. Corrocher
    Clinical and Experimental Medicine, 2005, 5 : 20 - 30
  • [28] INVESTIGATION OF THE CYP3A4 AND PON1 GENE VARIANTS IN TURKISH PATIENTS WITH FAMILIAL CORONARY ARTERY DISEASE
    Saydam, F.
    Degirmenci, I.
    Birdane, A.
    Ozdemir, M.
    Ozbayer, C.
    Ata, N.
    Gunes, H. V.
    JOURNAL OF HYPERTENSION, 2015, 33 : E379 - E379
  • [29] PON-1 Activity and Plasma 8-Isoprostane Concentration in Patients with Angiographically Proven Coronary Artery Disease
    Kuchta, Agnieszka
    Strzelecki, Adrian
    Cwiklinska, Agnieszka
    Toton, Magdalena
    Gruchala, Marcin
    Zdrojewski, Zbigniew
    Kortas-Stempak, Barbara
    Gliwinska, Anna
    Dabkowski, Kamil
    Jankowski, Maciej
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2016, 2016
  • [30] Total homocysteine in patients with angiographic coronary artery disease correlates with inflammation markers
    Schroecksnadel, Katharina
    Grammer, Tanja B.
    Boehm, Bernhard O.
    Maerz, Winfried
    Fuchs, Dietmar
    THROMBOSIS AND HAEMOSTASIS, 2010, 103 (05) : 926 - 935